The federal vaccine advisory committee’s guidance advising against giving the Oxford/AstraZeneca vaccine to seniors, despite Health Canada’s approval for its use by adults of all ages, should not be read as “static,” say public health officials, dismissing concerns that the conflicting advice puts provinces and territories in a bind.